ArticleJournal of the ASEAN Federation of Endocrine Societies2018

The Multicenter, Open-Label, Observational LEAD-Ph Study: Real-World Safety and Effectiveness of Liraglutide in Filipino Participants with Type 2 Diabetes.

Cecilia Jimeno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.